BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

Nanoscientists have demonstrated a method for loading nanoparticles with iron ions to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing ...

Simulations reveal details about the magnetic interactions between gadolinium contrast agents used in MRI scans and their environment. You can keep your best guesses. Engineers at Rice University's ...

A new study has shown that artificial intelligence could be used to dramatically reduce the amount of gadolinium used in MRI scans. The findings, which are being presented today at the annual meeting ...

(Nanowerk News) Rice University nanoscientists have demonstrated a method for loading iron inside nanoparticles to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast ...

(Reuters Health) - Women who don't realize they're pregnant when they undergo magnetic resonance imaging (MRI) may be exposed to a chemical that might not be safe for the fetus, a new report warns.

January 2, 2007 — The US Food and Drug Administration (FDA) warned healthcare professionals last week about additional reports of nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy ...

Qualitative ratings showed non-significant differences between the proposed method – a 10% level of gadolinium dose – and acquired full-dose contrast-enhanced MRI images, which was also verified with ...

Study Overview: This ongoing Phase 4 study, officially titled “Prospective Evaluation of Potential Effects of Repeated Gadolinium-based Contrast Agent (GBCA) Administrations of the Same GBCA on Motor ...

Dear Doctor: Not too long ago I developed symptoms of peripheral neuropathy that occurred almost immediately after having an MRI with gadolinium contrast. A physician confirmed that I had retained ...